StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ACOG

Alpha Cognition Inc. Common Stock

ACOG Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$8.43
+0.15 +1.81%

Key statistics

from XBRL data in SEC filings
Market cap
$184M
Revenue (TTM)
$10.8M
Net income (TTM)
-$25.4M
EPS (TTM)
$-1.39
P/E ratio
Dividend yield
Free cash flow
-$20.7M
Cash
$54.2M
Total assets
$69.2M
Gross margin
52-week range
$4.50 – $10.10

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Shareholder vote results Jun 23, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K/A Director or officer change May 1, 2026 8-K Director or officer change Apr 20, 2026 8-K Entered a material agreement Apr 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Regulation FD disclosure Mar 27, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Director or officer change Feb 23, 2026 8-K Director or officer change Jan 15, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K/A Changed accountants Oct 15, 2025 8-K Changed accountants Oct 14, 2025 8-K Entered a material agreement; Other events Oct 2, 2025 8-K Entered a material agreement Aug 22, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Director or officer change; Shareholder vote results Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Director or officer change Apr 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Director or officer change Feb 27, 2025 8-K Unregistered sale of equity Dec 20, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Modified rights of security holders Nov 5, 2024 8-K Director or officer change Oct 24, 2024 8-K Director or officer change Oct 9, 2024 8-K Amended charter or bylaws; Shareholder vote results Oct 3, 2024 8-K/A CURRENT REPORT Sep 26, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Sep 25, 2024 8-K Other events Aug 28, 2024 8-K Director or officer change Aug 27, 2024 8-K Results of operations (earnings release) Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Modified rights of security holders Aug 9, 2024 8-K Regulation FD disclosure Jul 29, 2024 8-K Entered a material agreement Jun 14, 2024
Other filings
4 Jul 28, 2026 4 Jul 24, 2026 SCHEDULE 13G/A Jul 24, 2026